Cargando…

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population

BACKGROUND: Next generation sequencing (NGS) is increasingly used in standard clinical practice to identify patients with potentially actionable mutations. Stratification of NGS mutation tiers is currently based on the European Society of Medical Oncology (ESMO) Scale for Clinical Actionability of M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nindra, Udit, Pal, Abhijit, Lea, Vivienne, Lim, Stephanie Hui-Su, Wilkinson, Kate, Asghari, Ray, Roberts, Tara L., Becker, Therese M., Farzin, Mahtab, Rutland, Tristan, Lee, Mark, MacKenzie, Scott, Ng, Weng, Wang, Bin, Lee, C. Soon, Chua, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553362/ https://www.ncbi.nlm.nih.gov/pubmed/37796807 http://dx.doi.org/10.1371/journal.pone.0292087

Ejemplares similares

A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour
por: Hong, Jun Hee, et al.
Publicado: (2022)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Clinical experience with multigene carrier panels in the reproductive setting
por: Terhaar, Catherine, et al.
Publicado: (2018)

Multigene panel predicting survival of patients with colon cancer
por: Li, Hao-Dong, et al.
Publicado: (2019)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
por: Leduc-Pessah, Heather, et al.
Publicado: (2022)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab
por: Nindra, Udit, et al.
Publicado: (2022)

Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients
por: Park, Jihye, et al.
Publicado: (2019)

Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT
por: McNamee, Nicholas, et al.
Publicado: (2023)

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
por: Shahnam, Adel, et al.
Publicado: (2023)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore
por: Wong, Edward S Y, et al.
Publicado: (2016)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
por: Ryu, Jin‐Sun, et al.
Publicado: (2020)

The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint
por: Xin, Ling, et al.
Publicado: (2017)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition
por: Tedaldi, Gianluca, et al.
Publicado: (2019)

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
por: Lin, Xiaozeng, et al.
Publicado: (2022)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Concurrent Paraneoplastic Dermatomyositis and Acquired C1 Esterase Inhibitor Deficiency in Primary Laryngeal Small Cell Carcinoma
por: Nindra, Udit, et al.
Publicado: (2021)

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015)

Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition
por: Martin-Morales, Lorena, et al.
Publicado: (2018)

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
por: Tedaldi, Gianluca, et al.
Publicado: (2020)

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
por: Valentini, Virginia, et al.
Publicado: (2023)

Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test
por: Kim, Yoo-Na, et al.
Publicado: (2022)

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
por: Dominguez-Valentin, Mev, et al.
Publicado: (2019)

Late Diagnosis of Wilson Disease, Initially Presenting as Cerebellar Atrophy Mimicking Spinocerebellar Ataxia, by Multigene Panel Testing
por: Kim, Min-Kyeong, et al.
Publicado: (2020)

A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Nindra, Udit, et al.
Publicado: (2023)

Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation–Negative Breast Cancer
por: Park, Ji Soo, et al.
Publicado: (2022)

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015)

Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer
por: Hirotsu, Yosuke, et al.
Publicado: (2015)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d5ivmjskb2l51ts42fu7ar7fc2